11:39 AM EST - Cynapsus Therapeutics Inc. : Announced that the U.S. Food and Drug Administrationhas granted Fast Track Designation for APL-130277, a product candidate for the treatment of OFF episodes in patients with Parkinson’s disease. Cynapsus Therapeutics Inc.
shares T.CTH are trading up $0.80 at $24.31.
